ImmunityBio, Inc. Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
ImmunityBio, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • ImmunityBio, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $2.38M, a 25% decline year-over-year.
  • ImmunityBio, Inc. annual Operating Lease, Payments for 2023 was $9.54M, a 6.87% decline from 2022.
  • ImmunityBio, Inc. annual Operating Lease, Payments for 2022 was $10.2M, a 13.4% increase from 2021.
  • ImmunityBio, Inc. annual Operating Lease, Payments for 2021 was $9.03M, a 15.2% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $2.38M -$795K -25% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q1 2023 $3.18M +$1.03M +47.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q1 2022 $2.15M +$472K +28.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q1 2021 $8.17M $1.68M +$324K +23.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 $7.84M $4.29M +$17K +0.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 $7.83M $1.1M +$100K +10% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-09
Q2 2020 $7.73M $1.1M +$100K +10% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-07
Q1 2020 $7.63M $1.36M +$55K +4.23% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q4 2019 $7.57M $4.27M Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 $1M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $1M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $1.3M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.